Long-term follow-up of relapsing/refractory ANCA associated vasculitis treated with the lymphocyte depleting antibody Alemtuzumab (CAMPATH-1H)
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- January 1, 2007
has subject area
- 1103 Clinical Sciences (FoR)
- Urology & Nephrology (Science Metrix)
published in
presented at event
- 44th ERA-EDTA Congress Conference